A novel EGFR exon 21 indel mutation in lung adenocarcinoma and response to dacomitinib: A case report.

Zhou T, Xiong Q, Hong C, Wang Q, Wang W, Xu C, Cai J, Yangtze River Delta Lung Cancer Cooperation Group

DOI: 10.1097/md.0000000000030269
Published: 2022 Aug 26
Container: Medicine
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1097/md.0000000000030269,
  title = {A novel EGFR exon 21 indel mutation in lung adenocarcinoma and response to dacomitinib: A case report.},
  author = {Zhou T and Xiong Q and Hong C and Wang Q and Wang W and Xu C and Cai J and Yangtze River Delta Lung Cancer Cooperation Group},
  year = {2022},
  journal = {Medicine},
  doi = {10.1097/md.0000000000030269},
  url = {https://doi.org/10.1097/md.0000000000030269}
}

RIS

TY  - JOUR
TI  - A novel EGFR exon 21 indel mutation in lung adenocarcinoma and response to dacomitinib: A case report.
AU  - Zhou T
AU  - Xiong Q
AU  - Hong C
AU  - Wang Q
AU  - Wang W
AU  - Xu C
AU  - Cai J
AU  - Yangtze River Delta Lung Cancer Cooperation Group
PY  - 2022
JO  - Medicine
DO  - 10.1097/md.0000000000030269
UR  - https://doi.org/10.1097/md.0000000000030269
ER  -

APA

T, Z., Q, X., C, H., Q, W., W, W., C, X., J, C., & Group, Y. R. D. L. C. C. (2022). A novel EGFR exon 21 indel mutation in lung adenocarcinoma and response to dacomitinib: A case report.. Medicine. https://doi.org/10.1097/md.0000000000030269

Source records

pubmed · retrieved 2026-09-27T12:01:01.426Z